Site Activity
This page provides a monthly listing of publication activity on the Medical Policy Portal including Policy Notifications, New Policies, Updated Policies, Coding Updates, Reissued Policies, and Archived Policies. To view publication activity from prior months, select Past Site Activity.

Past Site Activity
 
                                                                                                        

Notifications
The following Independence Blue Cross Medicare Advantage policies have been posted prior to their effective date.
MA05.017a, Home Oxygen Therapy
Notification: 06/01/2016 | Effective: 07/01/2016 | Posted: 06/01/2016
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update

MA05.044b, Durable Medical Equipment (DME)
Notification: 06/01/2016 | Effective: 07/01/2016 | Posted: 06/01/2016

MA05.057a, Upper Limb Prostheses
Notification: 06/01/2016 | Effective: 07/01/2016 | Posted: 06/01/2016
Type of policy change: Coverage and/or Reimbursement Position

MA07.033a, Nerve Conduction Studies (NCS) and Related Electrodiagnostic Studies
Notification: 06/02/2016 | Effective: 08/01/2016 | Posted: 06/02/2016
Type of policy change: Medical Coding

MA07.050a, Electromyography (EMG) Studies: Needle EMG, Surface EMG (SEMG)
Notification: 06/02/2016 | Effective: 08/01/2016 | Posted: 06/02/2016
Type of policy change: Medical Coding


New Policies
The following Medicare Advantage policies have been newly developed to communicate coverage and/or reimbursement positions, reporting requirements, and other processes and procedures for doing business with Independence Blue Cross.
MA11.111, Circumcision
Notification: 05/31/2016 | Effective: 06/29/2016 | Posted: 06/29/2016
Type of policy change: This is a new policy.


Updated Policies
The following Medicare Advantage policies have been reviewed and updated to communicate current coverage and/or reimbursement positions, reporting requirements, and other procedures for doing business with Independence Blue Cross.
MA11.054a, Cataract Surgery
Effective: 06/01/2016 | Posted: 06/01/2016
Type of policy change: Medical Necessity Criteria

MA05.031a, Patient Lifts
Notification: 05/04/2016 | Effective: 06/03/2016 | Posted: 06/03/2016

MA06.023b, Nerve Fiber Density Testing
Effective: 06/06/2016 | Posted: 06/06/2016
Type of policy change: General Description, Guidelines, or Informational Update

MA11.100b, Balloon Catheter Dilation of Sinus Ostia for Treatment of Chronic Rhinosinusitis
Effective: 06/15/2016 | Posted: 06/15/2016
Type of policy change: General Description, Guidelines, or Informational Update

MA08.024b, Interleukin-5 Antagonist for Severe Eosinophilic Asthma (e.g., Nucala®, Cinqair®)
Effective: 06/15/2016 | Posted: 06/15/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA06.019a, Measurement of Serum Antibodies to and Measurement of Serum Levels of Infliximab and Adalimumab
Effective: 06/20/2016 | Posted: 06/20/2016
Type of policy change: General Description, Guidelines, or Informational Update

MA07.055a, Allergy Immunotherapy
Effective: 06/20/2016 | Posted: 06/20/2016
Type of policy change: General Description, Guidelines, or Informational Update

MA11.005b, Deep Brain Stimulation (DBS)
Notification: 05/25/2016 | Effective: 06/24/2016 | Posted: 06/24/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA08.021a, Dofetilide (Tikosyn®) Use in the Inpatient Setting
Effective: 06/29/2016 | Posted: 06/29/2016
Type of policy change: Medical Coding

MA08.025b, Omalizumab (Xolair®)
Effective: 06/29/2016 | Posted: 06/29/2016
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update


Reissue Policies
The following Medicare Advantage policies have been reviewed, and no substantive changes were made.
MA05.054a, Urological Supplies
Reissue Effective: 06/08/2016 | Reissue Posted: 06/08/2016

MA08.039a, Plerixafor Injection (Mozobil®)
Reissue Effective: 06/22/2016 | Reissue Posted: 06/22/2016

MA08.074, Deoxycholic Acid (Kybella™)
Reissue Effective: 06/22/2016 | Reissue Posted: 06/22/2016

MA07.041a, Drug-Eluting Beads and Bland Embolization for the Treatment of Hepatic Malignancies
Reissue Effective: 06/22/2016 | Reissue Posted: 06/22/2016

MA07.040a, Transcatheter Arterial Chemoembolization (TACE) of Hepatic Malignancies
Reissue Effective: 06/22/2016 | Reissue Posted: 06/22/2016

MA07.017a, Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Reissue Effective: 06/22/2016 | Reissue Posted: 06/22/2016

MA11.049a, Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids
Reissue Effective: 06/22/2016 | Reissue Posted: 06/23/2016

MA11.039a, Cochlear Implantation
Reissue Effective: 06/22/2016 | Reissue Posted: 06/23/2016

MA07.021, Partial Coherence Interferometry
Reissue Effective: 06/22/2016 | Reissue Posted: 06/23/2016


Coding Update
The following Medicare Advantage policies have been reviewed and updated to add new and revised medical codes (e.g., ICD-9 and ICD-10 diagnosis codes; CPT® and HCPCS codes; revenue codes) and/or remove terminated medical codes.
MA07.047a, Pain Management of Peripheral Nerves by Injection
Effective: 06/01/2016 | Posted: 06/01/2016

MA00.010g, PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative Services
Effective: 06/10/2016 | Posted: 06/10/2016

MA08.078a, Sebelipase alfa (Kanuma®)
Effective: 07/01/2016 | Posted: 06/30/2016

MA08.079a, Daratumumab (Darzalex™)
Effective: 07/01/2016 | Posted: 06/30/2016










Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.